ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

41,851Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 315

$3.27M Total Retail Price of All Prescriptions

Rank: 1 out of 315

908 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 908 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

8% of this provider’s 908 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 40,111 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
AMLODIPINE BESYLATE 2,061 1,972 1 2
OMEPRAZOLE 1,869 1,768 2 9
SIMVASTATIN 1,714 1,649 3 1
ATORVASTATIN CALCIUM 1,585 1,544 10 4 5
ACTONEL 1,104 1,103 10 5 47
ALENDRONATE SODIUM 1,002 962 6 12
LEVOTHYROXINE SODIUM 966 965 7 6
LOSARTAN-HYDROCHLOROTHIAZIDE 759 738 8 17
METFORMIN HCL ER 758 747 10 9 33
NAMENDA 730 727 10 38
NEXIUM 710 691 11 54
LOSARTAN POTASSIUM 699 642 12 4
EXELON 687 676 13 121
METFORMIN HCL 687 660 13 7
GLIMEPIRIDE 683 677 15 32
DIOVAN 646 622 16 27
TAMSULOSIN HCL 604 598 17 21
CRESTOR 556 551 18 24
FUROSEMIDE 549 519 19 15
LISINOPRIL 525 477 20 3
LIDODERM 522 522 21 76
MELOXICAM 518 517 22 77
LOVAZA 501 472 23 64
CELEBREX 475 474 24 34
GABAPENTIN 462 436 25 37
DONEPEZIL HCL 440 440 26 28
ATELVIA 439 437 27 102
CIPROFLOXACIN HCL 412 396 28 58
DIOVAN HCT 411 406 29 56
CLOBETASOL PROPIONATE 392 382 30 82
MIRTAZAPINE 377 352 31 68
METOPROLOL TARTRATE 374 354 32 18
ATENOLOL 363 351 33 11
PANTOPRAZOLE SODIUM 343 343 34 35
RANEXA 318 312 35 145
AMLODIPINE BESYLATE-BENAZEPRIL 316 316 36 26
CARVEDILOL 307 307 37 22
JANUVIA 301 289 38 31
WARFARIN SODIUM 301 301 38 20
BYSTOLIC 297 290 40 73
CLOPIDOGREL 279 277 41 25
FENOFIBRATE 260 253 42 43
CITALOPRAM HBR 258 245 43 72
CLOTRIMAZOLE-BETAMETHASONE 252 249 44 132
POLYETHYLENE GLYCOL 3350 243 232 45 106
TRAMADOL HCL 243 232 45 59
POTASSIUM CHLORIDE 228 224 47 36
AVODART 228 228 47 113
MUPIROCIN 225 199 49 110
RANITIDINE HCL 221 195 50 42
FINASTERIDE 218 218 51 60
NAPROXEN 211 203 52 88
PREDNISONE 207 187 53 41
ADVAIR DISKUS 206 206 54 46
LOVASTATIN 201 193 55 8
PLAVIX 200 195 56 40
VESICARE 200 200 56 150
QUETIAPINE FUMARATE 192 181 58 143
ZOLPIDEM TARTRATE 191 177 59 29
MECLIZINE HCL 188 187 60 81
TRAZODONE HCL 177 161 61 93
PEN NEEDLE 175 154 62 91
JANUMET 171 156 63 83
LIPITOR 166 163 64 44
LACTULOSE 162 145 65 115
METOPROLOL SUCCINATE 161 149 66 13
ZENPEP 148 148 67 230
DIGOXIN 147 147 68 45
NASONEX 145 143 69 191
LISINOPRIL-HYDROCHLOROTHIAZIDE 144 132 70 50
HYDROXYZINE HCL 137 134 R 71 105
EXFORGE 133 133 72 107
NYSTATIN 132 113 73 211
AZOR 131 126 74 187
LANTUS SOLOSTAR 130 117 75 69
VALSARTAN-HYDROCHLOROTHIAZIDE 123 121 76 213
CARBIDOPA-LEVODOPA 120 109 77 136
CEFUROXIME 119 113 78 251
TRILIPIX 112 111 79 124
AVELOX 111 109 80 217
DALIRESP 107 83 81 259
HYDROCODONE-ACETAMINOPHEN 107 101 S3 81 19
SEROQUEL 105 99 83 262
LYRICA 104 94 84 126
MEGESTROL ACETATE 103 103 R 85 120
SINGULAIR 99 98 86 153
ALLOPURINOL 99 86 86 14
ONGLYZA 97 97 88 99
FELODIPINE ER 97 97 88 23
HYDROCHLOROTHIAZIDE 95 95 90 16
BACLOFEN 95 71 90 184
PRAVASTATIN SODIUM 92 92 92 10
FLECTOR 90 90 93 270
ESCITALOPRAM OXALATE 88 79 94 108
METRONIDAZOLE 87 82 95 274
RISPERIDONE 85 77 96 148
COMBIVENT 85 85 96 169
ISOSORBIDE MONONITRATE ER 84 84 98 92
TERAZOSIN HCL 81 80 99 63
KETOCONAZOLE 81 70 99 193
BENICAR HCT 80 80 101 126
ANDROGEL 80 77 S3 101 241
PROCTOSOL-HC 78 77 103 283
KOMBIGLYZE XR 78 67 103 172
FAMOTIDINE 77 76 105 75
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 72 105 149
EVISTA 77 76 105 48
LOPERAMIDE 75 74 108 159
METOCLOPRAMIDE HCL 75 57 108 206
MONTELUKAST SODIUM 70 70 110 220
AMOXICILLIN 70 65 110 65
ENABLEX 70 70 110 220
SPIRIVA 68 68 113 74
SAVELLA 66 66 114 296
GLIPIZIDE 65 50 115 30
NOVOLIN R 65 56 115 250
OLANZAPINE 64 64 117 300
TRAMADOL HCL-ACETAMINOPHEN 63 63 118 123
METHOTREXATE 62 62 119 171
TRIAMCINOLONE ACETONIDE 61 60 120 62
PROAIR HFA 61 61 120 52
FENTANYL 57 45 S2 122 160
TEKTURNA 57 57 122 207
NOVOLOG FLEXPEN 56 45 124 254
VOLTAREN 54 54 125 197
LANTUS 54 38 125 113
LEVETIRACETAM 54 46 125 189
IPRATROPIUM-ALBUTEROL 53 51 128 255
SANTYL 51 49 129 329
NITROFURANTOIN MONO-MACRO 50 49 130 332
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.